David Young - 14 Apr 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
President & CEO, Director, 10%+ Owner
Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
14 Apr 2023
Net transactions value
+$10,998
Form type
4
Filing time
14 Apr 2023, 18:16:56 UTC
Previous filing
13 Apr 2023
Next filing
12 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Purchase $10,998 +20,000 +4.9% $0.5499 430,424 14 Apr 2023 Direct
holding PCSA Common Stock 619,677 14 Apr 2023 By Young-Plaisance Revocable Trust
holding PCSA Common Stock 215,703 14 Apr 2023 By Family Entities
holding PCSA Common Stock 370,887 14 Apr 2023 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.